Novozymes and CHS released their first quarterly financial report after their merger into Novonesis. The report shows that the company achieved a 4% organic growth in sales in the first quarter of 2024. The organic growth of food and health biological solutions was 3%, of which the organic growth of the food and beverage business was 6%, mainly driven by strong growth in the dairy industry and steady growth in the baking industry. Looking by region, the Asia-Pacific region had the highest growth rate in the current quarter, with an organic growth rate of 13%. Novonesis will continue to maintain its sales and profit outlook for 2024, with an expected organic sales growth of 5% to 7%. (Source: Novonesis)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE